Skip to main content

Yung Zip Chemical Ind. Co., Ltd. (4102.TWO)

Taipei Exchange (Taiwan) Healthcare Drug Manufacturers - GeneralView data quality →
43.4Fair

ValueMarkers Composite Index

Top 12%#39,356 of 44,707
Slightly Undervalued

16% below intrinsic value ($1)

UndervaluedFair ValueOvervalued
Piotroski
4/9
Neutral
Beneish
-2.41
Low Risk
Altman
2.66
Grey Zone
DCF Value
$1
Undervalued
ROIC
-2.2%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Yung Zip Chemical Ind. Co., Ltd. (4102.TWO) — VMCI valuation read

Across 120 indicators, Yung Zip Chemical Ind. Co., Ltd. (4102.TWO) lands at VMCI 43/100. The Healthcare sector median is 50, so the 7-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on 4102.TWO in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, 4102.TWO trades at 19.0x earnings, 6% above the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 9.0% trails the Healthcare median (10.0%) by 1.0pp. On Risk, net debt to EBITDA of 3.1x is the binding constraint on the bear case for 4102.TWO on the trailing balance sheet.

4102.TWO fell 2.3% over the trailing 7 days, with a -13.0% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 4102.TWO’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.